Dec 2 (Reuters) - Access Bio Inc 950130.KQ :
* Says it signed contract with Bill & Melinda Gates
Foundation on Nov. 30, to support R&D for project of creating a
"Center for Advanced Accessible Diagnostices (CAAD)" to Catalyze
Next Generation Technologies for Resource-Limited Settings
* Says contract amount is 4.42 billion won
* Says contract period is from Nov. 30 to April 1, 2018
Source text in Korean: https://goo.gl/3s58cZ
Further company coverage: 950130.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))